$20.89
0.090.43%
Pre-Market: 8:24 AM EDT
Comments
Loading...
Celldex Therapeutics (CLDX) Forecast
NewsEarningsCelldex Therapeutics (CLDX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCelldex Therapeutics (NASDAQ:CLDX) Stock Quotes, Forecast and News Summary
Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Celldex Therapeutics (CLDX) stock?
You can purchase shares of Celldex Therapeutics (NASDAQ:CLDX) through any online brokerage.
Who are Celldex Therapeutics (CLDX) competitors?
Other companies in Celldex Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the forecast, or price target, for Celldex Therapeutics (CLDX) stock?
Celldex Therapeutics has a consensus price target of $63.33.
What is the current price for Celldex Therapeutics (CLDX)?
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $20.8897 last updated February 26, 2025 at 8:24 AM EST.
Does Celldex Therapeutics (CLDX) pay a dividend?
There are no upcoming dividends for Celldex Therapeutics.
When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?
Celldex Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.
Is Celldex Therapeutics (CLDX) going to split?
There is no upcoming split for Celldex Therapeutics.
What sector and industry does Celldex Therapeutics (CLDX) operate in?
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.